426 related articles for article (PubMed ID: 28823497)
1. Epithelial-mesenchymal transition and inflammation at the site of the primary tumor.
Dominguez C; David JM; Palena C
Semin Cancer Biol; 2017 Dec; 47():177-184. PubMed ID: 28823497
[TBL] [Abstract][Full Text] [Related]
2. Tumor microenvironment and epithelial mesenchymal transition as targets to overcome tumor multidrug resistance.
Erin N; Grahovac J; Brozovic A; Efferth T
Drug Resist Updat; 2020 Dec; 53():100715. PubMed ID: 32679188
[TBL] [Abstract][Full Text] [Related]
3. Molecular pathways: linking tumor microenvironment to epithelial-mesenchymal transition in metastasis.
Jung HY; Fattet L; Yang J
Clin Cancer Res; 2015 Mar; 21(5):962-968. PubMed ID: 25107915
[TBL] [Abstract][Full Text] [Related]
4. Epigenetic Regulation of Inflammatory Cytokine-Induced Epithelial-To-Mesenchymal Cell Transition and Cancer Stem Cell Generation.
Markopoulos GS; Roupakia E; Marcu KB; Kolettas E
Cells; 2019 Sep; 8(10):. PubMed ID: 31557902
[TBL] [Abstract][Full Text] [Related]
5. Interplay of Immunometabolism and Epithelial-Mesenchymal Transition in the Tumor Microenvironment.
Chou MY; Yang MH
Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34576042
[TBL] [Abstract][Full Text] [Related]
6. TGF-β-induced epithelial-mesenchymal transition: a link between cancer and inflammation.
Fuxe J; Karlsson MC
Semin Cancer Biol; 2012 Oct; 22(5-6):455-61. PubMed ID: 22627188
[TBL] [Abstract][Full Text] [Related]
7. IL-8, a novel messenger to cross-link inflammation and tumor EMT via autocrine and paracrine pathways (Review).
Long X; Ye Y; Zhang L; Liu P; Yu W; Wei F; Ren X; Yu J
Int J Oncol; 2016 Jan; 48(1):5-12. PubMed ID: 26548401
[TBL] [Abstract][Full Text] [Related]
8. Communication between EMT and PD-L1 signaling: New insights into tumor immune evasion.
Jiang Y; Zhan H
Cancer Lett; 2020 Jan; 468():72-81. PubMed ID: 31605776
[TBL] [Abstract][Full Text] [Related]
9. IL-8 signaling plays a critical role in the epithelial-mesenchymal transition of human carcinoma cells.
Fernando RI; Castillo MD; Litzinger M; Hamilton DH; Palena C
Cancer Res; 2011 Aug; 71(15):5296-306. PubMed ID: 21653678
[TBL] [Abstract][Full Text] [Related]
10. Pro-Tumoral Inflammatory Myeloid Cells as Emerging Therapeutic Targets.
Szebeni GJ; Vizler C; Nagy LI; Kitajka K; Puskas LG
Int J Mol Sci; 2016 Nov; 17(11):. PubMed ID: 27886105
[TBL] [Abstract][Full Text] [Related]
11. Cancer-related inflammation.
Candido J; Hagemann T
J Clin Immunol; 2013 Jan; 33 Suppl 1():S79-84. PubMed ID: 23225204
[TBL] [Abstract][Full Text] [Related]
12. Immunological Consequences of Epithelial-Mesenchymal Transition in Tumor Progression.
Chockley PJ; Keshamouni VG
J Immunol; 2016 Aug; 197(3):691-8. PubMed ID: 27431984
[TBL] [Abstract][Full Text] [Related]
13. Targeting Epithelial-Mesenchymal Transition (EMT) to Overcome Drug Resistance in Cancer.
Du B; Shim JS
Molecules; 2016 Jul; 21(7):. PubMed ID: 27455225
[TBL] [Abstract][Full Text] [Related]
14. The Recruitment of Neutrophils to the Tumor Microenvironment Is Regulated by Multiple Mediators.
SenGupta S; Hein LE; Parent CA
Front Immunol; 2021; 12():734188. PubMed ID: 34567000
[TBL] [Abstract][Full Text] [Related]
15. Narrower insight to SIRT1 role in cancer: A potential therapeutic target to control epithelial-mesenchymal transition in cancer cells.
Choupani J; Mansoori Derakhshan S; Bayat S; Alivand MR; Shekari Khaniani M
J Cell Physiol; 2018 Jun; 233(6):4443-4457. PubMed ID: 29194618
[TBL] [Abstract][Full Text] [Related]
16. Tumor Immune Microenvironment during Epithelial-Mesenchymal Transition.
Taki M; Abiko K; Ukita M; Murakami R; Yamanoi K; Yamaguchi K; Hamanishi J; Baba T; Matsumura N; Mandai M
Clin Cancer Res; 2021 Sep; 27(17):4669-4679. PubMed ID: 33827891
[TBL] [Abstract][Full Text] [Related]
17. The Roles of Stroma-Derived Chemokine in Different Stages of Cancer Metastases.
Hussain S; Peng B; Cherian M; Song JW; Ahirwar DK; Ganju RK
Front Immunol; 2020; 11():598532. PubMed ID: 33414786
[TBL] [Abstract][Full Text] [Related]
18. IL-6 and related cytokines as the critical lynchpins between inflammation and cancer.
Taniguchi K; Karin M
Semin Immunol; 2014 Feb; 26(1):54-74. PubMed ID: 24552665
[TBL] [Abstract][Full Text] [Related]
19. Epithelial-mesenchymal transition: Initiation by cues from chronic inflammatory tumor microenvironment and termination by anti-inflammatory compounds and specialized pro-resolving lipids.
Lee CH
Biochem Pharmacol; 2018 Dec; 158():261-273. PubMed ID: 30389404
[TBL] [Abstract][Full Text] [Related]
20. Inflammation and cancer stem cells.
Shigdar S; Li Y; Bhattacharya S; O'Connor M; Pu C; Lin J; Wang T; Xiang D; Kong L; Wei MQ; Zhu Y; Zhou S; Duan W
Cancer Lett; 2014 Apr; 345(2):271-8. PubMed ID: 23941828
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]